Rheumatoid arthritis associated interstitial lung disease in KwaZulu-Natal, South Africa: Clinical profile and treatment outcomes

M. Mitha (Durban (Kwa Zulu-Natal), South Africa), H. Ghammo (Durban (Kwa Zulu-Natal), South Africa), C. Connolly (Durban (Kwa Zulu-Natal), South Africa), K. Nyamande (Durban (Kwa Zulu-Natal), South Africa)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mitha (Durban (Kwa Zulu-Natal), South Africa), H. Ghammo (Durban (Kwa Zulu-Natal), South Africa), C. Connolly (Durban (Kwa Zulu-Natal), South Africa), K. Nyamande (Durban (Kwa Zulu-Natal), South Africa). Rheumatoid arthritis associated interstitial lung disease in KwaZulu-Natal, South Africa: Clinical profile and treatment outcomes. 804

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Population surveillance in North West Adelaide: physical activity associated with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005

Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome
Source: ERJ Open Res, 7 (3) 00856-2020; 10.1183/23120541.00856-2020
Year: 2021



Connective tissue associated lung disease treated with Cyclophosphamide in Durban, South Africa.
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Population surveillance in North West Adelaide - burden of respiratory disease
Source: Annual Congress 2005 - Information for the active clinician
Year: 2005


Population surveillance in North West Adelaide: the impact of diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD) on quality of life
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005

Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

A qualitative study on the development of pulmonary rehabilitation for patients with chronic lung disease in Kampala, Uganda
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Sarcoidosis in Johannesburg, South Africa: A retrospective study
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016

A development study of pulmonary rehabilitation for patients with chronic lung disease in Uganda
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Diet and related lifestyle, lung function and chronic obstructive pulmonary disease in Middle Eastern and African countries: A systematic review
Source: International Congress 2014 – Chronic and acute environmental exposure effect during childhood and in the elderly
Year: 2014

Subclinical tuberculosis disease and its treatment outcomes: a prospective cohort study in South Korea
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
Source: Eur Respir J 2002; 20: 799-805
Year: 2002



Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of Rajasthan, India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development
Source: Eur Respir J 2007; 29: 582-586
Year: 2007



Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Smoking and obstructive lung function disorders in three rural districts in Northwest Russia
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013


Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016